中国HIV-1B’/C亚型感染者对自身病毒中和作用与疾病进展关系的研究

www.yongyao.net　　2009-12-3 13:41:29　　来源：　　责任编辑：

分享到：

4 　参考文献
1 　Mc Cann C M,Song R J ,Ruprecht R M. Antibodies :can they protect against HIV infection ? [J ] . Curr Drug Targets Infect Disord ,2005 ;5 :95-111.
2 　Devito C ,Hinkula J ,Kaul R et al . Cross2clade HIV212specific neutralizingIgA in mucosal and systemic compartments of HIV212exposed ,persistently seronegative subjects [J ] . J Acquir Immune Defic Syndr ,2002 ; 30 : 413-420.
3 　Broliden K,Hinkula J ,Devito C et al . Functional HIV21 specific IgA antibodies in HIV21 exposed ,persistently IgG seronegative female sex workers[J ] . Immunol Lett ,2001 ;79 :29-36.
4 　Barker E ,Mackewicz C E ,Reyes2Teran G et al . Virological and immunological features of long2term human immunodeficiency virus2infected individuals who have remained asymptomatic compared with those who have progressed to acquired immunodeficiency syndrome [J ] . Blood ,1998 ;92 :3105-3114.
5 　Bures R ,Morris L ,Williamson C et al . Regional clustering of shared neutralization determinants on primary isolates of clade C human immunodefi ciency virus type 1 from South Africa[J ] . J Virol ,2002 ;76 :2233-2244.
6 　Polonis V R ,de Souza M S ,Darden J M et al . Human immunodeficiency virus type 1 primary isolate neutralization resistance is associated with the syncytium2inducing phenotype and lower CD4 cell counts in subtype CRF012AE2infected patients[J ] . J Virol ,2003 ;77 :8570-8576.
7 　Brandful J A ,Coetzer M E ,Cilliers T et al . Phenotypic characterization of HIV type 1 isolates from Ghana [J ] . AIDS Res Hum Retroviruses ,2007 ;23 :144-152.
8 　Polonis V R ,De Souza MS ,Chanbancherd P et al . HIV type 1 subtype Einfected patients with broadened ,dual (B/ E) V3 loop serology have increased cross2neutralizing antibodies [ J ] . AIDS Res Hum Retroviruses ,2001 ;17 :69-79.
9 　Mascola J R ,D’Souza P ,Gilbert P et al . Recommendations for the design and use of standard virus panels to assess neutralizing antibody responses elicited by candidate human immunodeficiency virus type 1 vaccines[J ] . JVirol ,2005 ;79 :10103-10107.
10 　Moore J P ,Burton D R. Urgently needed :a filter for the HIV21 vaccine pipeline[J ] . Nat Med ,2004 ;10 :769-771.
11 　Cao Y,Qin L ,Zhang L et al . Virologic and immunologic characterization of long2term survivors of human immunodeficiency virus type 1 infection[J ] . N Engl J Med ,1995 ;332 :201-208.
12 　Montefiori D C ,Pantaleo G,Fink L M et al . Neutralizing and infectionenhancing antibody responses to human immunodeficiency virus type 1 inlong2term nonprogressors[J ] . J Infect Dis ,1996 ;173 :60-67.
13 　黄　钦,梅　珊,曹韵贞. 不同病期HIV21 感染者血浆中和抗体研究[J ] . 中国性病艾滋病防治,2001 ;7(3) :202-205.
14 　Rogers P R ,Crofe M. Peptide dose ,affinity ,and time of differentiation can contribute to the Th1 / Th2 cytokine balance [J ] . J Immunol ,1999 ;163 :1205-1213.

来源:中国免疫学杂志作者:包名家,耿文清,崔华等